In Johnson & Johnson’s most recent clinical trial, researchers found that receiving two doses of the vaccine provided 94% efficiency against contracting coronavirus. Previously, Johnson & Johnson single dose had an 85% efficiency. The new clinical trial, compared the immunity of 32,000 volunteers who received one dose of Johnson & Johnson to those who received two doses eight weeks apart.